First Treatment in China for Morquio A Syndrome Earns Approval
Free-Photos / Pixabay

First Treatment in China for Morquio A Syndrome Earns Approval

According to a story from Market Screener, the biotechnology company BioMarin Pharmaceutical Inc. recently announced that the Chinese government has approved the company's drug elosulfase alfa (marketed at Vimizim) as…

Continue Reading First Treatment in China for Morquio A Syndrome Earns Approval
Close Menu